This site became the new ClinicalTrials.gov on June 19th. Learn more.
Show more
ClinicalTrials.gov Menu IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
ClinicalTrials.gov Menu IMPORTANT: Talk with a trusted healthcare professional before volunteering for a study. Read more...
ClinicalTrials.gov Menu
Give us feedback

Celecoxib Combined With Fluorouracil and Leucovorin in Treating Patients With Resected Stage III Adenocarcinoma (Cancer) of the Colon

This study has been completed.
Sponsor:
Collaborators:
Dutch Colorectal Cancer Group (DCCG)
Arbeitsgemeinschaft fur Internistische Onkologie
Onkologie
EFCR - Egyptian foundation for Cancer Research
EORTC GI Group (EORTC 40023)
Federation Francophone de Cancerologie Digestive
GCCD-APIO - Grupo Cooperativo do Cancro Digestivo da Associação Portuguesa de Investigação
Oncológica
Gruppo Italiano per lo studio dei Carcinomi dell'Apparato Digerente
GOCCI - Gruppo Oncologico Chirurgico Cooperativo Italiano
GOIRC - Gruppo Oncologico Italiano di Ricerca Clinica
SG - Scandinavian Group
TTD - Grupo Español para el Tratamiento de Tumores Digestivos
Information provided by (Responsible Party):
European Organisation for Research and Treatment of Cancer - EORTC
ClinicalTrials.gov Identifier:
NCT00085163
First received: June 10, 2004
Last updated: October 19, 2015
Last verified: October 2015
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: No date given
  Primary Completion Date: November 2005 (Final data collection date for primary outcome measure)